schedule
Showing 1 - 25 of >10,000
Decreasing Destructive Behavior, Increasing Functional Communicative Behavior Trial in New Brunswick, Somerset (Traditional
Not yet recruiting
- Decreasing Destructive Behavior
- Increasing Functional Communicative Behavior
- Traditional Schedule Thinning
- +2 more
-
New Brunswick, New Jersey
- +1 more
Mar 29, 2023
Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jun 27, 2023
Aggressive Prostate Cancer in Real Life: Initiation, Schedule
Completed
- Prostate Cancer
-
Paris, FranceIpsen Central Contact
Dec 20, 2022
Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)
Completed
- Gastrointestinal Stromal Tumors (GISTs)
- Imatinib Mesylate
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Spinal Deformity, Spinal Degenerative Disorder, Spinal Fusion Failure Trial in Columbus (Follow-up schedule: pre-operative
Recruiting
- Spinal Deformity
- +4 more
- Follow-up schedule: pre-operative baseline to index surgery
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
May 9, 2023
Pressure Ulcer, Ischemic, Ischemic Ulcer Trial in Paris (Positioning schedule)
Recruiting
- Pressure Ulcer
- +2 more
- Positioning schedule
-
Paris, Ile De France, FranceService de Réanimation Médico-chirurgicale. Hôpital Tenon, AP-HP
Oct 3, 2022
Influenza Trial (Reminder)
Not yet recruiting
- Influenza
- Reminder
- (no location specified)
Aug 6, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022
Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome Trial in Indianapolis (Morphine
Completed
- Neonatal Abstinence Syndrome
- +2 more
- Morphine PRN
- Morphine scheduled
-
Indianapolis, IndianaIndiana University Health Methodist Hospital
Sep 9, 2022
Rotavirus Infections, Diarrhea Trial (IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0,
Not yet recruiting
- Rotavirus Infections
- Diarrhea
- IRV on a 0- and 28-day schedule
- +3 more
- (no location specified)
Oct 8, 2023
Quadrivalent Influenza Vaccine Immunization Schedule for
Completed
- GCP
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
-
Jinan, Shandong, ChinaKou Zengqiang
Oct 17, 2023
ICU Delirium Trial in New Brunswick (Enteric feeding)
Recruiting
- ICU Delirium
- Enteric feeding
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
Jun 29, 2022
Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
- Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
- (no location specified)
Jun 6, 2023
Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)
Recruiting
- Locally Advanced Basal Cell Carcinoma
-
Brescia, ItalyAsst Degli Spedali Civili Di Brescia
Aug 3, 2022
Cigarette Smoker, Current Every Day Smoker, Current Smoker Trial in Houston (Internet Mobile Technology, Interview,
Active, not recruiting
- Cigarette Smoker
- +3 more
- Internet Mobile Technology
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19
Recruiting
- Covid19
- 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
- +3 more
-
Xinxiang, Henan, ChinaYanjin County Center for Disease Control and Prevention
Jun 15, 2022
Human Immunodeficiency Virus Trial in Atlanta (TDF/FTC Dose Schedule for Arm A, TDF/FTC Dose Schedule for Arm B)
Completed
- Human Immunodeficiency Virus
- TDF/FTC Dose Schedule for Arm A
- TDF/FTC Dose Schedule for Arm B
-
Atlanta, GeorgiaHope Clinic
Sep 20, 2022
COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)
Completed
- COVID-19
- CoronaVac/CoronaVac
- CoronaVac/BNT162b2
-
Bizerte, Mateur, Tunisia
- +4 more
Jan 4, 2023
COVID-19 Trial in Xuzhou (Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule, Two
Completed
- COVID-19
- Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule
- +11 more
-
Xuzhou, Jiangsu, ChinaSuining County Center for Disease Control and Prevention
Feb 22, 2022
Ear Barotrauma, Middle Ear Disease, Ear Diseases Trial in Sleepy Hollow (Compression Profile/Schedule: 15 minute Non-Linear
Recruiting
- Ear Barotrauma
- +6 more
- Compression Profile/Schedule: 15 minute Non-Linear compression from start of the daily treatment until treatment pressure is reached (45 fsw)
- Compression Profile/Schedule: 15 minute Linear compression from start of the daily treatment until treatment pressure is reached (45 fsw)
-
Sleepy Hollow, New YorkPhelps Hospital Northwell Health
Sep 29, 2022
Health-risk Behaviours, Drug Abuse Trial in Hong Kong (Health-risk behaviors, Theory of planned behavior, Self-determination
Not yet recruiting
- Health-risk Behaviours
- Drug Abuse
- Health-risk behaviors
- +5 more
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Jun 26, 2023
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
COVID-19 Trial in Nanjing (Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14,
Recruiting
- COVID-19
- Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14
- +7 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022
COVID-19 Trial in Nanjing (a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56,
Recruiting
- COVID-19
- a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56
- +7 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022
Head Neck Cancer Trial in Bern (Conventional follow up schedule with imaging, Deintensified follow up schedule without imaging)
Recruiting
- Head and Neck Cancer
- Conventional follow up schedule with imaging
- Deintensified follow up schedule without imaging
-
Bern, Switzerland
- +2 more
Nov 30, 2022